Zhongxing Jiang

Single-Cell Analysis of Target Antigens of CAR-T Reveals a Potential Landscape of “On-Target, Off-Tumor Toxicity”

Yinyin Zhang, Yingmei Li, Weijie Cao et al. · Frontiers in Immunology · 2021 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway

Dandan Chen, Ping Tang, Lingxiang Liu et al. · Cell Cycle · 2018 · 49 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Dysregulation of LncRNA ANRIL mediated by miR-411–3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α

Meng Wang, Huayan Zhao, Jinglan Zhang et al. · Experimental Cell Research · 2020 · 36 citations

Medicine, Molecular Biology, Oncology +17

Safety and efficacy of jaktinib in the treatment of Janus kinase <scp>inhibitor‐naïve</scp> patients with myelofibrosis: Results of a phase <scp>II</scp> trial

Yi Zhang, Hu Zhou, Zhongxing Jiang et al. · American Journal of Hematology · 2022 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

Xinfeng Chen, Binghe Tan, Haizhou Xing et al. · Cancer Immunology Immunotherapy · 2024 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17